Invo Fertility Financial Results
INVO Fertility reported Q3 2026 financial results featuring a 26% increase in total revenue to $2.2 million and a 28% growth in clinic-specific revenue. The company narrowed its net loss to $2.1 million and achieved its seventh consecutive quarter of positive clinic-level Adjusted EBITDA while significantly reducing liabilities by $5.5 million compared to year-end 2025.
- Term
- Q3 2026